# Lymphoseek® as Lymphoid Tissue Targeting Agents in Colon Cancer(CNC)

> **NCT01902953** · PHASE2 · COMPLETED · sponsor: **Maimonides Medical Center** · enrollment: 16 (actual)

## Conditions studied

- Colon Cancer
- Rectal Cancer

## Interventions

- **DRUG:** Lymphoseek and VBD Sln dissection

## Key facts

- **NCT ID:** NCT01902953
- **Lead sponsor:** Maimonides Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2021-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01902953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01902953, "Lymphoseek® as Lymphoid Tissue Targeting Agents in Colon Cancer(CNC)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01902953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*